Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1950 2
1951 1
1952 2
1955 1
1956 1
1958 1
1966 2
1968 1
1969 1
1970 2
1971 1
1973 1
1976 1
1977 1
1979 9
1981 1
1982 2
1983 1
1984 1
1985 2
1986 1
1987 6
1988 5
1989 3
1990 1
1991 2
1993 1
1994 1
1995 3
1996 1
1997 1
1999 1
2000 1
2001 3
2002 5
2003 7
2004 6
2005 9
2006 7
2007 4
2008 7
2009 24
2010 13
2011 12
2012 11
2013 13
2014 8
2015 10
2016 6
2017 2
2018 6
2019 5
2020 12
2021 10
2022 12
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

242 results

Results by year

Filters applied: . Clear all
Page 1
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial.
Pignata S, Scambia G, Schettino C, Arenare L, Pisano C, Lombardi D, De Giorgi U, Andreetta C, Cinieri S, De Angelis C, Priolo D, Casanova C, Rosati M, Greco F, Zafarana E, Schiavetto I, Mammoliti S, Cecere SC, Salutari V, Scalone S, Farolfi A, Di Napoli M, Lorusso D, Gargiulo P, Califano D, Russo D, Spina A, De Cecio R, Chiodini P, Perrone F; MITO investigators. Pignata S, et al. Lancet Oncol. 2023 Mar;24(3):286-296. doi: 10.1016/S1470-2045(23)00016-5. Epub 2023 Feb 14. Lancet Oncol. 2023. PMID: 37052965 Clinical Trial.
Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial.
Bernard L, Dinh A, Ghout I, Simo D, Zeller V, Issartel B, Le Moing V, Belmatoug N, Lesprit P, Bru JP, Therby A, Bouhour D, Dénes E, Debard A, Chirouze C, Fèvre K, Dupon M, Aegerter P, Mulleman D; Duration of Treatment for Spondylodiscitis (DTS) study group. Bernard L, et al. Lancet. 2015 Mar 7;385(9971):875-82. doi: 10.1016/S0140-6736(14)61233-2. Epub 2014 Nov 5. Lancet. 2015. PMID: 25468170 Clinical Trial.
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial.
Hardt K, Vandebosch A, Sadoff J, Le Gars M, Truyers C, Lowson D, Van Dromme I, Vingerhoets J, Kamphuis T, Scheper G, Ruiz-Guiñazú J, Faust SN, Spinner CD, Schuitemaker H, Van Hoof J, Douoguih M, Struyf F; ENSEMBLE2 study group. Hardt K, et al. Lancet Infect Dis. 2022 Dec;22(12):1703-1715. doi: 10.1016/S1473-3099(22)00506-0. Epub 2022 Sep 13. Lancet Infect Dis. 2022. PMID: 36113538 Free PMC article. Clinical Trial.
Mediterranean Bioconstructions Along the Italian Coast.
Ingrosso G, Abbiati M, Badalamenti F, Bavestrello G, Belmonte G, Cannas R, Benedetti-Cecchi L, Bertolino M, Bevilacqua S, Bianchi CN, Bo M, Boscari E, Cardone F, Cattaneo-Vietti R, Cau A, Cerrano C, Chemello R, Chimienti G, Congiu L, Corriero G, Costantini F, De Leo F, Donnarumma L, Falace A, Fraschetti S, Giangrande A, Gravina MF, Guarnieri G, Mastrototaro F, Milazzo M, Morri C, Musco L, Pezzolesi L, Piraino S, Prada F, Ponti M, Rindi F, Russo GF, Sandulli R, Villamor A, Zane L, Boero F. Ingrosso G, et al. Among authors: bevilacqua s. Adv Mar Biol. 2018;79:61-136. doi: 10.1016/bs.amb.2018.05.001. Epub 2018 Jun 30. Adv Mar Biol. 2018. PMID: 30012277 Review.
Anesthetic management of carotid endarterectomy: an update from Italian guidelines.
Bevilacqua S, Ticozzelli G, Orso M, Alba G, Capoccia L, Cappelli A, Cernetti C, Diomedi M, Dorigo W, Faggioli G, Giannace G, Giannandrea D, Giannetta M, Lessiani G, Marone EM, Mazzaccaro D, Migliacci R, Nano G, Pagliariccio G, Petruzzellis M, Plutino A, Pomatto S, Pulli R, Sirignano P, Vacirca A, Visco E, Moghadam SP, Lanza G, Lanza J. Bevilacqua S, et al. J Anesth Analg Crit Care. 2022 Jun 6;2(1):24. doi: 10.1186/s44158-022-00052-9. J Anesth Analg Crit Care. 2022. PMID: 37386522 Free PMC article.
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. J Transl Med. 2020. PMID: 33087150 Free PMC article. Clinical Trial.
Vandetanib as a potential treatment for breast cancer.
De Luca A, D'Alessio A, Maiello MR, Gallo M, Bevilacqua S, Frezzetti D, Morabito A, Perrone F, Normanno N. De Luca A, et al. Among authors: bevilacqua s. Expert Opin Investig Drugs. 2014 Sep;23(9):1295-303. doi: 10.1517/13543784.2014.942034. Epub 2014 Aug 4. Expert Opin Investig Drugs. 2014. PMID: 25089348 Review.
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2021 Oct 21;19(1):442. doi: 10.1186/s12967-021-03094-9. J Transl Med. 2021. PMID: 34674735 Free PMC article. No abstract available.
Taking the sparkle off the sparkling time.
Perosa M, Guerranti C, Renzi M, Bevilacqua S. Perosa M, et al. Among authors: bevilacqua s. Mar Pollut Bull. 2021 Sep;170:112660. doi: 10.1016/j.marpolbul.2021.112660. Epub 2021 Jun 26. Mar Pollut Bull. 2021. PMID: 34182304
[HIV-tuberculosis coinfection].
Bévilacqua S, Rabaud C, May T. Bévilacqua S, et al. Ann Med Interne (Paris). 2002 Mar;153(2):113-8. Ann Med Interne (Paris). 2002. PMID: 12037493 Review. French.
242 results